• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    GenVec, Inc. (GNVC)

    -NasdaqCM
    0.78 Down 0.01(1.28%) Apr 29, 4:00PM EDT
    |After Hours : 0.83 Up 0.05 (6.41%) Apr 29, 5:57PM EDT
    Prev Close:0.79
    Open:0.76
    Bid:N/A
    Ask:0.98 x 4000
    1y Target Est:5.00
    Beta:3.56072
    Earnings Date:May 6 - May 10 (Est.)
    Day's Range:0.75 - 0.80
    52wk Range:0.35 - 3.69
    Volume:105,193
    Avg Vol (3m):124,656
    Market Cap:13.47M
    P/E (ttm):N/A
    EPS (ttm):-0.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GNVC

    Comparison

    Symbol% ChgMkt Cap
    GNVCDown 1.28%13.47M
    MRKDown 1.61%151.89B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.21
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.30
    Quarterly EPS Est (Mar-16) :-0.09
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    GenVec, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback